Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
The TRIUMPH program has six more Phase 3 readouts expected through 2026
The weight regain observed after the discontinuation of currently approved GLP-1 and GIP/GLP-1 receptor agonists represents an unmet need for anti-obesity regimens with sustained efficacy
JOE ROGAN: Right, right
J Appl Physiol (1985) 105(4):13331341
As demand grows and the market evolves, were committed to working with payors to best support their members while balancing costs
Both mimic the hormone GLP-1, or glucagon like peptide 1 (tirzepatide mimics both GLP-1 and GIP, or gastric inhibitory polypeptide hormone) which controls the release of insulin from the pancreas and regulates blood sugar levels
